GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,466.50p
   
  • Change Today:
    -22.00p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,293.50
  • Currency: UK Pounds
  • Shares Issued: 4,129.58m
  • Volume: 1,137,338
  • Market Cap: £60,560m
  • RiskGrade: 129
  • Beta: 0.01

Latest ShareCast News

EMA accepts GSK's application to expand Nucala use

By Josh White

Date: Monday 24 Mar 2025

(Sharecast News) - GSK said on Monday that the European Medicines Agency has accepted its application to expand the use of 'Nucala', or mepolizumab, to include patients with chronic obstructive pulmonary disease (COPD) who have an eosinophilic phenotype.

GSK ShareCast News

FDA to review GSK's depemokimab 03-Mar-2025 ShareCast
London close: Stocks little changed after UK dat... 21-Feb-2025 ShareCast
GSK seen as potential target for activist invest... 21-Feb-2025 ShareCast
London close: Stocks slip as US jobless claims r... 20-Feb-2025 ShareCast
GSK 5-in1 meningitis drug gets US approval 17-Feb-2025 ShareCast

GSK Regulatory News

Transaction in Own Shares 31-Mar-2025 07:00 RNS
Director/PDMR Shareholding 28-Mar-2025 15:30 RNS
Transaction in Own Shares 28-Mar-2025 07:00 RNS
Transaction in Own Shares 27-Mar-2025 07:00 RNS
Transaction in Own Shares 26-Mar-2025 07:00 RNS

GSK Newspaper Links

GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph
GlaxoSmithKline tops table in effort to get drug... 17-Nov-2014 Guardian

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,466.50p
Change Today -22.00p
% Change -1.48 %
52 Week High 1,812.50
52 Week Low 1,293.50
Volume 1,137,338
Shares Issued 4,129.58m
Market Cap £60,560m
Beta 0.01
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.97% below the market average66.97% below the market average66.97% below the market average66.97% below the market average66.97% below the market average
14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average
Price Trend
2.97% above the market average2.97% above the market average2.97% above the market average2.97% above the market average2.97% above the market average
30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average
Income
62.82% above the market average62.82% above the market average62.82% above the market average62.82% above the market average62.82% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
47.2% below the market average47.2% below the market average47.2% below the market average47.2% below the market average47.2% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 15
Sell 3
Strong Sell 0
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 20-Feb-25 14-Nov-24
Paid 10-Apr-25 09-Jan-25
Amount 16.00p 15.00p

Trades for 31-Mar-2025

Time Volume / Share Price
11:21 1 @ 1,467.00p
11:21 792 @ 1,466.33p
11:21 0 @ 1,467.00p
11:20 2 @ 1,466.50p
11:20 87 @ 1,466.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page